149 related articles for article (PubMed ID: 15629405)
1. Induction of endothelial cell damage by hCMV molecular mimicry.
Lunardi C; Bason C; Corrocher R; Puccetti A
Trends Immunol; 2005 Jan; 26(1):19-24. PubMed ID: 15629405
[TBL] [Abstract][Full Text] [Related]
2. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage.
Dolcino M; Puccetti A; Barbieri A; Bason C; Tinazzi E; Ottria A; Patuzzo G; Martinelli N; Lunardi C
Lupus; 2015 Apr; 24(4-5):419-32. PubMed ID: 25801885
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.
Lunardi C; Bason C; Navone R; Millo E; Damonte G; Corrocher R; Puccetti A
Nat Med; 2000 Oct; 6(10):1183-6. PubMed ID: 11017152
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis.
Lin YS; Yeh TM; Lin CF; Wan SW; Chuang YC; Hsu TK; Liu HS; Liu CC; Anderson R; Lei HY
Exp Biol Med (Maywood); 2011 May; 236(5):515-23. PubMed ID: 21502191
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis and infections.
Randone SB; Guiducci S; Cerinic MM
Autoimmun Rev; 2008 Oct; 8(1):36-40. PubMed ID: 18706530
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of human cytomegalovirus infection and cellular targets.
Gerna G; Baldanti F; Revello MG
Hum Immunol; 2004 May; 65(5):381-6. PubMed ID: 15172435
[TBL] [Abstract][Full Text] [Related]
8. Do infections facilitate the emergence of systemic sclerosis?
Grossman C; Dovrish Z; Shoenfeld Y; Amital H
Autoimmun Rev; 2011 Mar; 10(5):244-7. PubMed ID: 20863912
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.
Varani S; Frascaroli G; Landini MP; Söderberg-Nauclér C
Rev Med Virol; 2009 May; 19(3):131-45. PubMed ID: 19367559
[TBL] [Abstract][Full Text] [Related]
10. Human CMV infection of porcine endothelial cells increases adhesion receptor expression and human leukocyte recruitment.
Ghielmetti M; Millard AL; Haeberli L; Bossart W; Seebach JD; Schneider MK; Mueller NJ
Transplantation; 2009 Jun; 87(12):1792-800. PubMed ID: 19543055
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma: from cell and molecular mechanisms to disease models.
Abraham DJ; Varga J
Trends Immunol; 2005 Nov; 26(11):587-95. PubMed ID: 16168711
[TBL] [Abstract][Full Text] [Related]
12. Role of viral infections in the etiopathogenesis of systemic sclerosis.
Moroncini G; Mori S; Tonnini C; Gabrielli A
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):3-7. PubMed ID: 23910606
[TBL] [Abstract][Full Text] [Related]
13. Modulation of HLA expression in human cytomegalovirus immune evasion.
Lin A; Xu H; Yan W
Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.
Marou E; Liaskos C; Simopoulou T; Efthymiou G; Dardiotis E; Katsiari C; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):863-869. PubMed ID: 28124759
[TBL] [Abstract][Full Text] [Related]
15. Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells.
Caposio P; Musso T; Luganini A; Inoue H; Gariglio M; Landolfo S; Gribaudo G
Antiviral Res; 2007 Mar; 73(3):175-84. PubMed ID: 17070604
[TBL] [Abstract][Full Text] [Related]
16. The microvascular endothelium in scleroderma.
Kahaleh B
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v14-5. PubMed ID: 18784128
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
Rölle A; Olweus J
APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
[TBL] [Abstract][Full Text] [Related]
18. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology.
Loenen WA; Bruggeman CA; Wiertz EJ
Semin Immunol; 2001 Feb; 13(1):41-9. PubMed ID: 11289798
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis.
Neidhart M; Kuchen S; Distler O; Brühlmann P; Michel BA; Gay RE; Gay S
Arthritis Rheum; 1999 Feb; 42(2):389-92. PubMed ID: 10025936
[No Abstract] [Full Text] [Related]
20. Consequences of human cytomegalovirus mimicry.
Michelson S
Hum Immunol; 2004 May; 65(5):465-75. PubMed ID: 15172446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
